Fairmount Healthcare Fund Reports a $10 Million VRDN Buy

Steve Strazza
January 24, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Fairmount Healthcare Fund II L.P.

The investment firm revealed a purchase of 476,190 shares of Viridian Therapeutics Inc $VRDN, equivalent to $9.9 million.

Article Sales Message

Know the trading behavior of …

  • Senators
  • House Of Representatives
  • C-Suite Executives
  • Hedge Fund Managers
  • Other Big-Power Players

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Log in or subscribe
Filed Under: